These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 15882283

  • 21. Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.
    Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli S, Turgan C.
    Artif Organs; 2009 Oct; 33(10):844-54. PubMed ID: 19681840
    [Abstract] [Full Text] [Related]

  • 22. Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels.
    Osawa M, Tian W, Horiuchi H, Kaneko M, Umetsu K.
    Hum Genet; 2005 Feb; 116(3):146-51. PubMed ID: 15592877
    [Abstract] [Full Text] [Related]

  • 23. Fetuin-A serum levels are not correlated to kidney function in long-lived subjects.
    Bellia C, Tomaiuolo R, Caruso A, Sasso BL, Zarrilli F, Carru C, Deiana M, Zinellu A, Pinna S, Castaldo G, Deiana L, Ciaccio M.
    Clin Biochem; 2012 Jun; 45(9):637-40. PubMed ID: 22425942
    [Abstract] [Full Text] [Related]

  • 24. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM, Schlieper G, Heussen N, Holzmann S, Busch B, Evenepoel P, Vanholder R, Meijers B, Meert N, Fassbender WJ, Floege J, Jahnen-Dechent W, Ketteler M.
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [Abstract] [Full Text] [Related]

  • 25. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
    Panichi V, Taccola D, Rizza GM, Consani C, Migliori M, Filippi C, Paoletti S, Sidoti A, Borracelli D, Panicucci E, Giovannini L.
    J Nephrol; 2004 Aug; 17(5):715-20. PubMed ID: 15593040
    [Abstract] [Full Text] [Related]

  • 26. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study.
    Akdag I, Yilmaz Y, Kahvecioglu S, Bolca N, Ercan I, Ersoy A, Gullulu M.
    Nephron Clin Pract; 2008 Aug; 108(2):c99-c105. PubMed ID: 18212491
    [Abstract] [Full Text] [Related]

  • 27. A translational approach to micro-inflammation in end-stage renal disease: molecular effects of low levels of interleukin-6.
    Memoli B, Salerno S, Procino A, Postiglione L, Morelli S, Sirico ML, Giordano F, Ricciardone M, Drioli E, Andreucci VE, Bartoli LD.
    Clin Sci (Lond); 2010 May 14; 119(4):163-74. PubMed ID: 20380647
    [Abstract] [Full Text] [Related]

  • 28. Association of dialysate calcium concentration with fetuin A level and carotid intima-media thickness in peritoneal dialysis patients.
    Liang J, Wang Z, Liu G, Zhan J, Jiang L, Jiang Z.
    Ren Fail; 2014 Feb 14; 36(1):65-8. PubMed ID: 24028708
    [Abstract] [Full Text] [Related]

  • 29. High serum hyaluronan indicates poor survival in renal replacement therapy.
    Stenvinkel P, Heimbürger O, Wang T, Lindholm B, Bergström J, Elinder CG.
    Am J Kidney Dis; 1999 Dec 14; 34(6):1083-8. PubMed ID: 10585318
    [Abstract] [Full Text] [Related]

  • 30. Increased circulating inflammatory proteins predict a worse prognosis with valvular calcification in end-stage renal disease: a prospective cohort study.
    Wang AY, Lam CW, Wang M, Chan IH, Yu CM, Lui SF, Sanderson JE.
    Am J Nephrol; 2008 Dec 14; 28(4):647-53. PubMed ID: 18292652
    [Abstract] [Full Text] [Related]

  • 31. Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients.
    Maréchal C, Schlieper G, Nguyen P, Krüger T, Coche E, Robert A, Floege J, Goffin E, Jadoul M, Devuyst O.
    Clin J Am Soc Nephrol; 2011 May 14; 6(5):974-85. PubMed ID: 21527649
    [Abstract] [Full Text] [Related]

  • 32. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?
    Pertosa G, Simone S, Ciccone M, Porreca S, Zaza G, Dalfino G, Memoli B, Procino A, Bonomini M, Sirolli V, Castellano G, Gesualdo L, Ktena M, Schena FP, Grandaliano G.
    Am J Kidney Dis; 2009 Mar 14; 53(3):467-74. PubMed ID: 19167798
    [Abstract] [Full Text] [Related]

  • 33. Serum fetuin-A is associated with the components of MIAC(malnutrition, inflammation, atherosclerosis, calcification) syndrome in different stages of chronic kidney disease.
    Mutluay R, Konca Değertekin C, Işıktaş Sayılar E, Derici Ü, Gültekin S, Gönen S, Arınsoy ST, Sindel MŞ.
    Turk J Med Sci; 2019 Feb 11; 49(1):327-335. PubMed ID: 30761853
    [Abstract] [Full Text] [Related]

  • 34. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K, Suliman ME, Qureshi AR, Axelsson J, Martola L, Heimbürger O, Barany P, Stenvinkel P, Lindholm B.
    Blood Purif; 2008 Feb 11; 26(3):284-90. PubMed ID: 18421213
    [Abstract] [Full Text] [Related]

  • 35. Gene polymorphism association studies in dialysis: the nutrition-inflammation axis.
    Stenvinkel P, Pecoits-Filho R, Lindholm B, DialGene Consortium.
    Semin Dial; 2005 Feb 11; 18(4):322-30. PubMed ID: 16076356
    [Abstract] [Full Text] [Related]

  • 36. Biomarkers of vascular calcification and mortality in patients with ESRD.
    Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS.
    Clin J Am Soc Nephrol; 2014 Apr 11; 9(4):745-55. PubMed ID: 24458076
    [Abstract] [Full Text] [Related]

  • 37. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study.
    Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA.
    Circulation; 2007 May 15; 115(19):2533-9. PubMed ID: 17485576
    [Abstract] [Full Text] [Related]

  • 38. Potential Correlation Between Circulating Fetuin-A and Pentraxin-3 With Biochemical Parameters of Calcification in Hemodialysis Patients.
    Hashemi J, Joshaghani HR, Akaberi A, Hesari Z, Ghanbari R, Mohammadzadeh M, Golshan AR.
    Arch Iran Med; 2017 Dec 01; 20(12):752-755. PubMed ID: 29664315
    [Abstract] [Full Text] [Related]

  • 39. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
    Sun J, Axelsson J, Machowska A, Heimbürger O, Bárány P, Lindholm B, Lindström K, Stenvinkel P, Qureshi AR.
    Clin J Am Soc Nephrol; 2016 Jul 07; 11(7):1163-1172. PubMed ID: 27281698
    [Abstract] [Full Text] [Related]

  • 40. Association of serum fetuin A with truncal obesity and dyslipidemia in non-diabetic hemodialysis patients.
    Chen HY, Chiu YL, Hsu SP, Pai MF, Lai CF, Peng YS, Kao TW, Hung KY, Tsai TJ, Wu KD.
    Eur J Endocrinol; 2009 May 07; 160(5):777-83. PubMed ID: 19228823
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.